Recent studies found that fecal markers of intestinal inflammation, such as fecal calprotectin (routinely used for diagnosing and monitoring IBD) and possibly markers of intestinal barrier permeability, such as fecal zonulin, are elevated in people with PD (Schwiertz et al., 2018; Mulak et al., 2019). The gene discussed is HP; the disease is Parkinson disease.